+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Problem of drug-resistant tuberculosis and the way of its solution

Problem of drug-resistant tuberculosis and the way of its solution

Problemy Tuberkuleza 1999(6): 17-20

Drug-resistant tuberculosis in the Ukraine and in other countries as well is a great important problem. The presence of drug-resistant Mycobacteria worsens clinical and bacteriological responses to therapy, prolongs hospital stay, and increases costs. The novel derivative of rifampicin, rifabutin, produced by Pharmacia & Upjohn under the trade name Mycobutin is more effective and safe than rifampicin. Rifabutin is approved for clinical application for tuberculosis and other mycobacterial infections. It is also recommended for rifampicin-resistant tuberculosis.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 047080354

Download citation: RISBibTeXText

PMID: 10715949

Related references

Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease. Mikrobiyoloji Bulteni 45(1): 181-195, 2011

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest 136(2): 420-425, 2009

Drug-resistant tuberculosis; serious problem. New York State Journal of Medicine 80(10): 1541-1545, 1980

Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clinical Infectious Diseases 54(6): E51-E54, 2012

Analysis of mutational characteristics of the drug-resistant gene katG in multi-drug resistant Mycobacterium tuberculosis L-form among patients with pneumoconiosis complicated with tuberculosis. Molecular Medicine Reports 9(5): 2031-2035, 2014

Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group. International Journal of Tuberculosis and Lung Disease 2(4): 303-311, 1998

Multi-drug resistant tuberculosis: an iatrogenic problem. Bioscience Trends 4(2): 48-55, 2010

The Problem of Infection with Drug-Resistant Microorganisms-Tuberculosis. Clinic All-Round 12: 1527-1533, 1963

Drug resistance rates of Mycobacterium tuberculosis strains in Austria between 1995 and 1998 and molecular typing of multidrug-resistant isolates. The Austrian Drug Resistant Tuberculosis Study Group. Epidemiology and Infection 124(3): 523-528, 2000

Multi drug resistant pulmonary tuberculosis a continuing problem. Drug Intelligence & Clinical Pharmacy8: 430-436, 1979

Survey of pharmacoeconomic studies on the problem of drug resistant tuberculosis. 2006

Survey of pharmacoeconomic studies on the problem of drug resistant tuberculosis. Antibiotiki i Khimioterapiia 51(11-12): 51-53, 2006

Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Ethiopian Medical Journal 40(1): 79-86, 2002

The Problem and Management of Drug-Resistant Cases of Pulmonary Tuberculosis in Kenya. East African Medical Journal 41: 436-440, 1964

The making of a public health problem: multi-drug resistant tuberculosis in India. Health Policy and Planning 28(4): 375-385, 2013